Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 5, 1999, Pages 1611-1616

  Camacho Hübner, Cecilia ^a,e   Woods, Katie A ^a   Miraki Moud, Farideh ^a   Hindmarsh, Peter C ^b   Clark, Adrian J ^a   Hansson, Yngve ^c   Johnston, Atholl ^a   Baxter, Robert C ^d   Savage, Martin O ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c PFIZER INC   (United States)

^d UNIVERSITY OF SYDNEY   (Australia)

^e Department of Endocrinology and Chemical Endocrinology ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INSULIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; CASE REPORT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INHIBITION; GENE DELETION; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MALE; PRIORITY JOURNAL;

EID: 0033323796     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.5.5649     Document Type: Article

References (38)

1. Is growth hormone deficiency a viable diagnosis?
2. Intrauterine growth retardation and post natal growth failure associated with deletion of the IGF-I gene
3. Role of insulin-like growth factors in embryonic and postnatal growth
4. Mice carrying null mutations of the genes encoding insuLin-like growth factor (igf-i) an type 1 IGF receptor (igf1r)
5. IGF-I is required for normal embryonic growth in mice
6. Insulin-like growth factors and their binding proteins
7. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome)
8. Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome-a clinical research center study
9. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency
10. Laron syndrome-clinical features, molecular pathology and treatment
11. Growth hormone insensitivity syndromes: A preliminary report on changes in insulin-like growth factors and their binding proteins during treatment with recombinant insulin-like growth factor I
12. Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency
13. Variations in the pattern of pubertal changes in boys
14. A monoclonal antibody to human insulin-like growth factor-I: Characterization, use in radioimmunoassay and effect on the biological activities of the growth factor
15. Measurement of insulin-like growth factor-II in physiological fluids and tissues. An improved extraction procedure and radioimmunoassay for human and rat fluids
16. Circulating levels and molecular distribution of the acid-labile (α) subunit of the high molecular weight insulin-like growth factor binding protein complex
17. Immunoblot studies of the IGF related acid-labile subunit
18. Effect of short-term fasting on free/dissociable insulin-like growth factor-I concentrations in normal human serum
19. Nicotinamide and insulin secretion in normal subjects
20. MODFIT: A pharmacokinetics computer program
21. A distribution method for analysing the baseline of pulsatile endocrine signals as exemplified by 24-hour growth hormone profiles
22. Fetal growth: An endocrine perspective
23. Insulin-like growth factors I and -II in healthy man. Estimations of half-lives and production rates
24. The effect of recombinant human insulin-like growth factor (IGF)-I treatment of growth hormone secretion in two subjects with growth hormone insensitivity (Laron syndrome)
25. The effects of recombinant insulin-like growth factor-I administration on growth hormone levels an insulin requirements in adolescents with type I (insulin dependent) diabetes mellitus
26. Monitoring of growth hormone replacement therapy in adults, based on measurement of serum markers
27. Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses t a single dose of growth hormone
28. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously
29. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects
30. Clinical studies of IGFBP-2 by radioimmunoassay
31. The RIA for IGFBP-2 in man-a meagre catch?
32. Lack of growth hormone effect on insulin-associated suppression of insulin-like growth factor binding protein-1 in humans
33. Insulin regulates the serum levels of low molecular weight insulin-like growth factor binding protein
34. Glucocorticoids and insulin regulate expression of the human gene for insulin-like growth factor binding protein 1 through proximal promotor element
35. The modified minimal model: Application to mesurement of insulin-sensitivity in children
36. Insulin resistance in short children with intrauterine growth retardation
37. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth